S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
LON:BTG

BTG Share Forecast, Price & News

GBX 840
+1.00 (+0.12%)
(As of 08/19/2019)
Add
Compare
Today's Range
840
840
50-Day Range
840
840
52-Week Range
512.50
853
Volume
271,742 shs
Average Volume
960,389 shs
Market Capitalization
£3.26 billion
P/E Ratio
29.47
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive BTG News and Ratings via Email

Sign-up to receive the latest news and ratings for BTG and its competitors with MarketBeat's FREE daily newsletter.


BTG logo

About BTG

BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications. This segment also provides interventional vascular products consisting of EKOS system, an ultrasonic catheter drug delivery device used in the treatment of blood clots; Varithena for the treatment of varicose veins; and PneumRx Coil for the treatment of emphysema, a debilitating lung disease. The Pharmaceuticals segment offers antidote products, such as CroFab for the treatment of crotalid snake envenomations; DigiFab for the treatment of digoxin toxicity; and Voraxaze for high-dose methotrexate toxicity. The Licensing segment provides Zytiga for treatment of prostate cancer; Two-Part Hip Cup; and Lemtrada. The company also manufactures and commercializes therapeutic ultrasound devices, and roxwood systems, as well as develops venous thrombus management devices. The company was formerly known as British Technology Group International plc and changed its name to BTG plc in March 1995. BTG plc was founded in 1948 and is headquartered in London, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
1,631
Year Founded
N/A

Sales & Book Value

Annual Sales
£914.10 million
Cash Flow
GBX 90.80 per share
Book Value
GBX 355.80 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£3.26 billion
Optionable
Optionable

Company Calendar

Last Earnings
5/15/2018
Today
1/25/2022

MarketRank

Overall MarketRank

0.99 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












BTG (LON:BTG) Frequently Asked Questions

How were BTG's earnings last quarter?

BTG plc (LON:BTG) announced its earnings results on Tuesday, May, 15th. The company reported $32.90 EPS for the quarter, beating analysts' consensus estimates of $29.80 by $3.10.
View BTG's earnings history
.

Who are BTG's key executives?

BTG's management team includes the following people:
  • Dr. Louise Makin MA, Ph.D.(Cantab), MBA, DBE, CEO & Exec. Director (Age 58)
  • Mr. Duncan Kennedy A.C.A., B.Sc., CFO & Director
  • Dr. Peter Stratford, Chief Technical Officer & Head of Innovation (Age 52)
  • Mr. Andy Burrows, VP of Corp. & Investor Relations
  • Dr. Paul Mussenden, Gen. Counsel, Head of Strategic Affairs & Company Sec.

What other stocks do shareholders of BTG own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BTG investors own include Bodycote (BOY), Rapid7 (RPD), Editas Medicine (EDIT), Portola Pharmaceuticals (PTLA), Vectura Group (VEC), Bank of America (BAC), B2Gold (BTO), Serco Group (SRP), Tahoe Resources (TAHO) and Advanced Micro Devices (AMD).

What is BTG's stock symbol?

BTG trades on the London Stock Exchange (LON) under the ticker symbol "BTG."

How do I buy shares of BTG?

Shares of BTG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is BTG's stock price today?

One share of BTG stock can currently be purchased for approximately GBX 840.

How much money does BTG make?

BTG has a market capitalization of £3.26 billion and generates £914.10 million in revenue each year.

How many employees does BTG have?

BTG employs 1,631 workers across the globe.

What is BTG's official website?

The official website for BTG is www.btgplc.com.

Where are BTG's headquarters?

How can I contact BTG?

BTG's mailing address is 5 Fleet Place, LONDON, EC4M 7RD, United Kingdom. The company can be reached via phone at +44-20-75750000.


This page was last updated on 1/25/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.